Newsletter Subject

Releases Soon: $7 Catalyst Play With 2X Potential

From

biotechbreakouts.com

Email Address

kyle@biotechbreakouts.com

Sent On

Thu, Dec 3, 2020 01:53 PM

Email Preheader Text

Dear Trader, I’ve mentioned to you how I believe I’ve uncovered the #1 turnaround stock?

Dear Trader, I’ve mentioned to you how I believe I’ve uncovered the #1 turnaround stock… And why this $7 stock can DOUBLE very soon. Given the way the stock finished the day on Wednesday, I’m afraid it may get away from me. That’s why I’m carefully stalking this play at the opening bell to see whether the stock gets to my entry. If it does, I’ll send an alert to subscribers and let them know I’ll be on LIVE to trade this stock. Why am I so eager to buy shares of this stock? Well, there’s one catalyst in it that reminds me of one of my previous “longer-term” plays. You see, corporate insiders have made some hefty purchases. With Opko Health (OPK), one of my previous special situation catalyst plays… I noticed the same action, and here’s what happened with the stock.* Subscribers took that idea and made it their own…** Of course, I’m not guaranteeing you my upcoming POTUS Catalyst Play will be another winner, but I can guarantee you that I’ve done my homework. This $7 stock on my radar right now is a little different. Not only does it have a slew of insider purchases recently… but it’s got some star power behind it. This stock is invested in not one, but two of the most influential celebrities’ companies... And I wouldn’t be surprised if that helps this stock to DOUBLE its market cap. Listen, the stock is already moving and it might be corporate insiders buying shares again, but we’ll have to wait and see whether Form 4 filings come out again. [I’m ready to pull the trigger as soon as the opening bell.]( It won’t matter to you anyway because you still haven’t subscribed to get in on this unique learning opportunity. [I really don’t know why because you’ll be able to watch me trade it live...]( And gain access to all of this... [And two added bonuses, for a measly $49.]( I mean that comes out to just $1 per week. Normally, you would have to pay hundreds more for this deal... and once all the spots fill up, expect to see prices skyrocket. Right now, you have a rare chance to join in on the action for just $1 per week]([.]( Once you sign up, you’ll be onboarded so you know where to look for everything. Additionally, I’ll give subscribers a heads up and alert you via the RagingBull app and email before I go LIVE to reveal and place the trade. [Don’t miss out on this no-brainer offer](. Kyle Dennis *Results presented are not typical and may vary from person to person. Please review our full disclaimer located at ragingbull.com/disclaimer. **RagingBull does NOT track or verify subscribers' individual trading results and these individual experiences should NOT be understood as typical as or representative. Please see our Testimonials Disclaimer here: . RagingBull, LLC 62 Calef Hwy. #233, Lee, NH 03861 [Click Here to stop receiving emails from kyle@biotechbreakouts.com]( [Unsubscribe from all RagingBull emails]( DISCLAIMER: To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at [(. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. AnyRagingBull Service offered is for educational and informational purposes only and should NOT beconstrued as a securities-related offer or solicitation, or be relied upon as personalizedinvestment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor(IA), or IA representative with the U.S. Securities and Exchange Commission, any state securitiesregulatory authority, or any self-regulatory organization. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services. However, Ragingbull.com, LLC, its owners, and itsemployees may purchase, sell, or hold long or short positions in securities of the companies mentioned inthis communication. If you have a current active subscription with Biotech Breakouts you will need to contact us here if you want to cancel your subscription. Opting out of emails does not remove you from your service at BiotechBreakouts.com.

Marketing emails from biotechbreakouts.com

View More
Sent On

31/07/2021

Sent On

31/07/2021

Sent On

17/07/2021

Sent On

09/07/2021

Sent On

08/07/2021

Sent On

08/07/2021

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.